Position in VRTX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$300,521
+$30,365 QoQ
Shares Held
605
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,243
of 1,746 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aries Wealth Management holds $2,513,233 across 8 Biotechnology names. VRTX ranks #3 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
4,000 | $979,080 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
25,000 | $974,000 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
605 | $300,521 | |
| 4 | VSTM |
Verastem, Inc.
|
30,833 | $117,782 | |
| 5 | ABEO |
Abeona Therapeutics Inc.
|
12,500 | $77,250 | |
| 6 | EDIT |
Editas Medicine, Inc.
|
12,500 | $40,500 | |
| 7 | MTVA |
MetaVia Inc.
|
10,000 | $14,300 | |
| 8 | TCRX |
TScan Therapeutics, Inc.
|
10,000 | $9,800 |
All Filings in VRTX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $300,521 | 605 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $270,156 | 605 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $274,282 | 605 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $236,942 | 605 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $269,346 | 605 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $293,316 | 605 | Shares | Sole | 2025-04-17 | |
| 2024-09-30 | $220,913 | 475 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $222,642 | 475 | Shares | Sole | 2024-07-25 | |
| No filing history on record for this holder in this stock. | ||||||